Is Intraperitoneal Tobramycin Ototoxic in CAPD Patients?

1991 ◽  
Vol 11 (2) ◽  
pp. 156-161 ◽  
Author(s):  
Paul Nikolaidis ◽  
Stephen Vas ◽  
Victor Lawson ◽  
Lorraine Kennedy-Vosu ◽  
April Bernard ◽  
...  
Keyword(s):  
Concomitant Treatment ◽  
Speech Discrimination ◽  
Duration Of Treatment ◽  
Cochlear Function ◽  
Threshold Test ◽  
Speech Reception ◽  
Significant Difference ◽  
Ototoxic Drugs ◽  
A Prospective Study

In 40 CAPD patients treated for peritonitis, the authors did a prospective study of ototoxic effects of intraperitoneal tobramycin. They evaluated cochlear function in pure-tone threshold audiograms over a range of frequencies from 250–10, 000 Hz, in the speech-reception threshold test and in the speech-discrimination test. These tests were performed within 48 hours of initiation of tobramycin treatment and within 2 or 3 weeks of the drug's discontinuation. With the aminoglycoside doses used in this study, no statistical difference between the mean baseline and mean follow-up hearing levels was seen in these 40 patients. However, according to the standard criteria of ototoxicity, the hearing in 10 of 40 patients (25%) deteriorated after tobramycin, while it improved in seven patients (17.5%). In the remaining 23 (57.5%), hearing remained stable. With respect to the risk factors for ototoxicity such as advanced age, increased duration of treatment, elevated plasma aminoglycoside levels, concomitant treatment with other ototoxic drugs, pre-existing hearing loss, renal dysfunction and hyperthermia, no statistically significant difference was demonstrated between the patients with deteriorated, stable or improved hearing. The results of this study do not confirm that tobramycin given intraperitoneally to CAPD patients produces auditory toxicity. The hearing deterioration observed in 10 patients may be due to synergistic factors. The improvement observed in 7 patients could not be explained.

scholarly journals THU0521 EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS UNDER METHOTREXATE TREATMENT. UTILITY OF FIBROSCAN AND BIOMARKERS IN ROUTINE CLINICAL PRACTICE.

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 499.2-500
Author(s):  
A. De Diego Sola ◽  
M. Vaamonde Lorenzo ◽  
A. Castiella Eguzkiza ◽  
M. J. Sánchez Iturri ◽  
N. Alcorta Lorenzo ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Metabolic Syndrome ◽  
Liver Fibrosis ◽  
Controlled Study ◽  
Type I ◽  
Concomitant Treatment ◽  
Duration Of Treatment ◽  
Significant Difference ◽  
Apri Score ◽  
The Mean

Background:Despite therapeutic advances in recent years, methotrexate (MTX) remains the gold standard for the treatment of rheumatoid arthritis (RA). Among the side effects that have been blamed on it are liver fibrosis (LF) and cirrhosis, although late studies have failed to show such a relation1,2. The only validated test in the diagnosis of LF is biopsy. Given the relevance of MTX in the treatment of RA, it is important to evaluate non-invasive diagnostic options for LF such as transitional elastography (FibroScan, FS).Objectives:To evaluate the percentage of LF in RA patients treated with MTX. Secondly, to assess the correlation between altered liver function, RA activity, and LF. To determine whether dose and/or duration of treatment with MTX may affect the development of LF in such patients.Methods:We did a prospective study between February 2019 and January 2020. Patients affected of RA treated with MTX were included. Patients with basal liver disease (hepatitis B, hepatitis C and steatohepatitis), alcohol consumption, type I diabetes mellitus, chronic renal failure, heart failure, obesity and concomitant treatment with leflunomide or antiretrovirals were excluded. Demographic, clinical, analytical and therapeutic variables were collected. Liver fibrosis was assessed by FS in kilopascals (kpa) and using the APRI score. RA activity was assessed by DAS28 score. Continuous variables are described with mean and standard deviation (SD), and qualitative variables are shown with absolute value and percentage. Spearman’s and Mann-Whitney’s U tests were used for the bivariate analysis.Results:Fifty patients were included (Table 1 and 2). Of these, 38 were women (76%) with mean age of 61.8 years (SD 11.7) and mean RA evolution time of 13.7 years (SD 8.2). The mean DAS28 at the visit was 2.39 (SD 1.1). The FS showed an average of 4.8 kpa (SD 2). The mean duration of treatment with MTX was 85.8 months (SD 93.3) and that of AD-MTX was 5414.6mg (SD 5011). Patients were divided into those with DA-MTX greater than 4000mg (21, 42%) and less than 4000mg (29, 58%) and no significant differences were found in terms of LF in FS (p 0.637) or APRI scale (p 0.806). No significant differences were found in terms of treatment duration either. Six patients (12%) had elevated aspartate aminotransferase (AST) and 9 (18%) had elevated alanine aminotransferase (ALT). No significant difference was found in FS values in relation to ALT, but it was with elevated AST (p 0.021). Similarly, differences were found in APRI based on AST (p 0.045). Metabolic syndrome was collected in 4 patients (8%) without significant differences with FS or APRI values. There were no significant differences in LF depending on gamma-glutamyl transpeptidase (GGT) values.Conclusion:FS and APRI score are useful for the determination of LF in RA patients treated with MTX. There is no evidence of a relationship between AD-MTX and LF by FS or APRI. AST values may be related to the presence of fibrosis as determined by FS or APRI. and the presence of the metabolic syndrome are not.References:[1]G.L. Erre, et al. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography. European Journal of Internal Medicine 69 (2019) 57–63. Internet.[2]R. Conway et al. Risk of liver injury among methotrexate users: a meta-analysis of randomised controlled trials. Semin Arthritis Rheum 2015 Oct;45(2):156–62. Internet.Disclosure of Interests:None declared

scholarly journals A prospective study on outcome of function after proximal row carpectomy

2019 ◽  
Vol 6 (1) ◽  
pp. 44
Author(s):  
Chaitanya Gadi ◽  
S. M. Venugopal ◽  
Bhaskaranand Kumar ◽  
Karthik Gudaru
Keyword(s):  
Prospective Study ◽  
Grip Strength ◽  
Neuromuscular Disorders ◽  
Wrist Flexion ◽  
Proximal Row Carpectomy ◽  
Significant Difference ◽  
Post Traumatic ◽  
A Prospective Study ◽  
Traumatic Arthritis

<p class="abstract"><strong>Background:</strong> Proximal row carpectomy (PRC) is a procedure with varied indications. The purpose of this study was to evaluate functional outcomes with PRC in wrist flexion deformities, neuromuscular disorders and also post-traumatic wrist arthritis.</p><p class="abstract"><strong>Methods:</strong> A prospective study was performed on all patients who underwent PRC between April 2015 and December 2017, in BIRRD (T) hospital, Tirupati, Andhra Pradesh with a minimum follow up of 6 months. Outcome was assessed in terms of range of motion (ROM), grip strength, quick disabilities of the arm, shoulder, and hand (QDASH) score and pain score. Data was analyzed using the Student t-test.<strong></strong></p><p class="abstract"><strong>Results:</strong> Thirty-two patients underwent PRC of which 12 are neuromuscular disorders, 10 are wrist flexion deformities, 10 are post-traumatic wrist arthritis. On the final follow-up, significant improvement in ROM was observed in wrist flexion deformities and neuromuscular disorders, whereas grip strength and QDASH scores showed a significant difference in post-traumatic wrist arthritis. Pain was studied only in post-traumatic wrist arthritis, all were very much pleased with pain reduction.</p><p class="abstract"><strong>Conclusions:</strong> PRC is fairly a reliable procedure for all the indications in our study. We consider that PRC is a promising procedure in correcting wrist flexion deformities. Though there has been significant improvement in all the parameters for all the cases, we consider this procedure is best suited for post-traumatic arthritis group.</p>

scholarly journals P577 Withdrawal of thiopurines in patients with Ulcerative Colitis in remission

2021 ◽  
Vol 15 (Supplement_1) ◽  
pp. S534-S534
Author(s):  
C Amor Costa ◽  
C Suárez Ferrer ◽  
J Poza Cordón ◽  
J L Rueda García ◽  
M Sánchez Azofra ◽  
...  
Keyword(s):  
Risk Factors ◽  
Ulcerative Colitis ◽  
Standard Deviation ◽  
Adverse Effects ◽  
Medical Decision ◽  
Concomitant Treatment ◽  
Duration Of Treatment ◽  
The Mean ◽  
Time To Relapse

Abstract Background Thiopurines (TP) are widely used in monotherapy in patients with ulcerative colitis (UC), mainly for the maintenance of remission in case of corticodependence or corticoresistance after cyclosporine use. However, these are drugs with significant side effects, especially in the long term. The optimal duration of treatment with TP remains unknown, so it is important to determine the risk factors for relapse in order to identify the group of patients in which treatment can be withdrawn. Methods A retrospective study was performed. Patients with UC in remission, in maintenance treatment with TP, who had discontinued the drug due to either maintained remission or the onset of adverse effects were included. Results 26 patients were included, 1 with proctitis, 9 with left colitis and 16 with pancolitis. 24 (92.31%) were treated with azathioprine and 2 (7.69%) with mercaptopurine. The mean treatment time with TP was 68.09 months (standard deviation 56.65). 11 patients (42.31%) discontinued TP due to adverse effects and the remaining patients (57.69%) discontinued it by medical decision because they were in prolonged remission. After withdrawal of TP, 92.34% of patients continued treatment with mesalazine and the remaining 7.69% without concomitant treatment. During follow-up, 10 patients (38.4%) relapsed and 16 patients (61.53%) had no relapse until the end of follow-up. The mean time from TP withdrawal to the onset of relapse was 69.15 months (standard deviation 52.53). Of the 10 patients who presented a flare, 5 (50%) were controlled by optimizing the dose of mesalazine, 4 (40%) required the addition of oral corticosteroids and 1 (10%) required biologics. No significant differences were found when comparing the time to relapse if the reason for discontinuation of TP was having had an adverse effect (65.05 months) or maintained remission (79.79 months) (p=0.42). No statistically significant differences were found in time to relapse when comparing time on TP treatment, presence of concomitant treatment with mesalazine or active smoking. Conclusion One third of patients relapsed after TP withdrawal. Discontinuation of TP in patients with UC in remission should be individualized according to the patient’s risk factors, the indication and the duration of treatment.

scholarly journals Effect of persistence of left ventricular hypertrophy and left atrial dilatation after aortic valve replacement on early outcomes and survival: a prospective study

2019 ◽  
Vol 6 (10) ◽  
pp. 3786
Author(s):  
Hari Krishna Murthy P. ◽  
Abha Chandra
Keyword(s):  
Aortic Valve ◽  
Left Ventricular Hypertrophy ◽  
Aortic Stenosis ◽  
Left Atrial ◽  
Ventricular Hypertrophy ◽  
Severe Aortic Stenosis ◽  
Left Ventricular ◽  
Significant Difference ◽  
A Prospective Study

Background: The objective of the study was to evaluate the early outcomes and survival in patients with severe aortic stenosis associated with concentric left ventricular hypertrophy following aortic valve replacement.Methods: This is a prospective study done at SVIMS, Tirupati, from June 2014 to September 2015 evaluating out comes and survival in patients undergoing primary isolated aortic valve replacement (AVR) for severe aortic stenosis, severe aortic stenosis with mild aortic regurgitation and severe aortic stenosis with moderate aortic regurgitation.Results: A total of 40 cases 26 males and 14 females aged 18 to 60 years (mean age, 48.5±13.4 years) underwent elective AVR. Left ventricular end diastolic diameter (p=0.008) at 6 months, a statistically highly significant difference in left ventricular mass  preoperatively, at discharge, at 3rd and 6th month follow up. The difference in mean left ventricular mass index (LVMI) had declined from 244.425 to 141.100 at 6 months, showing a statistically highly significant difference in LVMI preop, at discharge, at 3rd month and at 6th month follow up.Conclusions: Patients with preoperative increase in LVMI, with large left atrial diameter carries a strong predictor of postoperative mortality for patients undergoing aortic valve surgery. We also conclude that there will be significant regression of LVMI following successful AVR. But, the decrease in LVMI is maximum during early three months and it is minimal though significant in the later course of follow up. 

scholarly journals Comparison of the Effectiveness of Emotionally Focused Couple Therapy and Self-compassion-based Therapy On Emotion Regulation In Women Affected by Infidelity

2021 ◽  
Vol 30 (2) ◽  
pp. 130-143
Author(s):  
Zohreh Teymouri ◽  
◽  
Mina Mojtabaei ◽  
Seyed Mohammad Reza Rezazadeh ◽  
◽  
...  
Keyword(s):  
Emotion Regulation ◽  
Emotional Regulation ◽  
Couples Therapy ◽  
Couple Therapy ◽  
Duration Of Treatment ◽  
Self Compassion ◽  
Marital Infidelity ◽  
Significant Difference ◽  
Quasi Experimental

Background: Marital infidelity is a crisis for couples and families. identifying an effective treatment approach at the lowest cost can be effective in preventing and intervening in injuries caused by infidelity. Objective: The aim of this study was to compare the effectiveness of emotion-based couple therapy and self-compassion-based therapy on emotion regulation in women affected by infidelity. Methods: This quasi-experimental study was designed as pre-test-post-test with follow-up. The study population included all couples involved in marital infidelity who referred to Iranmehr Counseling and Psychological Services Center in Rasht, Iran in 2020, from which 20 couples were selected as the sample by available sampling method. Granfsky emotion regulation questionnaire was used to collect data and emotion-focused couple therapy sessions and self-compassion-based therapy were performed for 16 sessions of 4 hours (one treatment every two hours) on a weekly basis. After three months of treatment sessions, couples also participated in a follow-up session in order to measure the duration of treatment. Data were analyzed using combined analysis of variance. Results: The results showed that both therapies are effective in increasing the emotional regulation of couples, but there is no significant difference between emotion-oriented couples therapy and compassion-based therapy on emotion regulation (F = 1.57 and P = 0.218). Conclusion: Both treatment approaches in counseling centers were very effective in helping incompatible couples to improve and reduce marital problems, increasing satisfaction, especially in couples affected by infidelit

Correlation Between MRI Findings and Clinical Impairment In Patients With Shoulder Adhesive Capsulitis: A Prospective Study

2020 ◽  
Author(s):  
Romain GILLET ◽  
Francois ZHU ◽  
Pierre PADOIN ◽  
Gabriella HOSSU ◽  
Aymeric RAUCH ◽  
...  
Keyword(s):  
Signal Intensity ◽  
Adhesive Capsulitis ◽  
Mri Findings ◽  
Significant Difference ◽  
Clinical Impairment ◽  
Pain Duration ◽  
One Year ◽  
The One ◽  
A Prospective Study

Abstract Objectives: MRI diagnostic criteria of shoulder adhesive capsulitis (AC) are widely used, but there is little information available on the association between MRI findings and clinical impairment. The aim of our study was to determine the correlation of MRI findings with the Constant-Murlay Score (CMS), pain duration, and symptoms at the one-year follow-up in AC patients. Methods: MRI of 132 patients with a clinical diagnosis of shoulder AC were prospectively studied. A radiologist examined all patients and completed the CMS just prior to MRI. Pain duration was assessed. The signal intensity and the maximal thickness of the inferior glenohumeral (IGHL) and coracohumeral (CHL) ligaments were measured by two radiologists. Medical record analysis was performed in a sub-group of 49 patients to assess correlation approximately one year after the MRI examination. Results: There was a significant difference in mean pain duration score (3.8 ± 1.2 versus 3.2 ± 0.9 and 3.8 ± 1.2 versus 3.2 ± 0.9 respectively for readers 1 and 2) and in mean mobility scores (15.7 ± 8 points versus 19.6 ± 10.1 points and 15.8 ± 8.2 points versus 19.4 ± 10 points respectively for readers 1 and 2) in patients with a high IGHL signal compared to those with a low signal (P < .05). IGHL was thicker in patients with clinical improvement at one-year follow-up compared to those presenting clinical stability or worsening (P < .05). Conclusion: In shoulder AC patients, the degree of signal intensity at the IGHL was inversely related to shoulder pain duration and range of motion, and a thickened IGHL indicated a favorable outcome at one-year follow-up.

Short Implants in Maxillary and Mandibular Rehabilitations: Interim Results (6 to 42 Months) of a Prospective Study

2015 ◽  
Vol 41 (1) ◽  
pp. 50-55 ◽  
Author(s):  
Silvio Taschieri ◽  
Stefano Corbella ◽  
Raffaella Molinari ◽  
Massimo Saita ◽  
Massimo Del Fabbro
Keyword(s):  
Sample Size ◽  
Cumulative Survival ◽  
Short Implants ◽  
Significant Difference ◽  
Upper Jaw ◽  
Maxilla And Mandible ◽  
A Prospective Study ◽  
Bone Height ◽  
Larger Sample

The aim of this single-cohort study was to evaluate clinical survival and success of partial rehabilitation supported by reduced-length implants in maxilla and mandible. Data from 53 short implants placed in 41 patients are presented. Before surgery mean residual bone height was 6.21 ± 1.05 mm in the upper jaw and 10.73 ± 1.63 mm in the mandible. None of the implants failed, and the cumulative survival rate was 100% at 1 year after prosthetic loading. Mean peri-implant bone loss was 0.69 ± 0.24 mm for maxillary implants and 0.73 ± 0.23 mm for mandibular implants, and there was no significant difference between the 2 jaws. No complications were recorded. Despite the limitations of this study concerning study design and sample size, short implants may be considered effective in supporting partial rehabilitation in both maxilla and mandible. More well-designed studies with a larger sample size and longer follow-up are needed to validate the use of short implants.

Carotid Intraplaque Neovascularization Predicts Ischemic Stroke Recurrence in Patients with Carotid Atherosclerosis

Gerontology ◽  
2021 ◽  
pp. 1-8
Author(s):  
Yan Song ◽  
Ying Dang ◽  
Jichang Wang ◽  
Hui Cai ◽  
Jun Feng ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Carotid Stenosis ◽  
Carotid Atherosclerosis ◽  
Proportional Hazards ◽  
Cox Proportional Hazards ◽  
Stroke Recurrence ◽  
Contrast Enhanced ◽  
Significant Difference ◽  
A Prospective Study

<b><i>Introduction:</i></b> This study aimed to examine whether intraplaque neovascularization (IPN) of carotid plaques, as characterized by contrast-enhanced ultrasound (CEUS), is associated with ischemic stroke recurrence in patients with carotid atherosclerosis. <b><i>Methods:</i></b> We conducted a prospective study of consecutive patients with a recent stroke and at least one atherosclerotic plaque in the carotid artery on the side consistent with symptoms. All patients underwent CEUS after their first admission. IPN was graded on the basis of the presence and location of microbubbles within each plaque. <b><i>Results:</i></b> We eventually included 155 patients, all of whom underwent IPN analysis. After a follow-up of 24 months, we recorded 25 (16.1%) stroke recurrences in the whole population. All the recurrences occurred in patients presenting IPN. There was significant difference in the IPN between the 2 groups (<i>p</i> = 0.002). In the final Cox proportional-hazards multivariable models, IPN of grade 2 was independently associated with the risk of stroke recurrence (HR = 4.535; 95% CI: 1.892–10.870; <i>p</i> = 0.001). This association remained after adjusting for the degree of carotid stenosis (HR = 3.491; 95% CI: 1.410–8.646; <i>p</i> = 0.007). <b><i>Conclusions:</i></b> IPN was an independent predictor of stroke recurrence in patients with a recent ischemic stroke and carotid atherosclerosis. In predicting stroke recurrence, IPN may be an earlier indicator than carotid stenosis and may help stratify the risk of stroke recurrence.

scholarly journals Minimally Invasive Non-Endoscopic Correction for Sagittal Craniosynostosis in Children Aged Below 6 Months

2021 ◽  
Vol 9 (D) ◽  
pp. 294-299
Author(s):  
Ayman Farghal ◽  
Khaled Bassim ◽  
Amr Mostafa Elkatatny
Keyword(s):  
Minimally Invasive ◽  
Length Of Hospital Stay ◽  
Sagittal Craniosynostosis ◽  
Significant Difference ◽  
Duration Of Surgery ◽  
Long Term Follow Up ◽  
Good Cosmetic ◽  
Endoscopic Correction ◽  
A Prospective Study

AIM: Object of this study is to determine effectiveness of this procedure used in this study which is minimally invasive non endoscopic correction for sagittal craniosynostosis in children below 6 months. METHODS: A prospective study was done in Neurosurgery children unit, Abu Elreash Japanese children hospital, Cairo university, Egypt, for patients with non syndromatic sagittal craniosynostosis. The variables analyzed; OFD, BPD, CI pre. & postoperative, age of patients at time of surgery, sex, duration of surgery and length of hospital stay. RESULTS: Our results shows statistically significant difference between pre-operative with post-operative after 2 days, post-operative follow-up, and follow-up after 1 year for OFD, BPD and CI. CONCLUSIONS: Internal helmet technique used in correction of sagittal synostosis in children below 6 months old giving good cosmetic results with the following advantages, (1) short surgery time, (2) small wound, (3) no much blood loss, (4) immediate good cosmetic result, (5) no need to use external devices which reduces the cost, family load, and child suffering, and (6) no need for long-term follow-up.

scholarly journals The value of a patient global assessment in management of sarcoidosis

2021 ◽  
Author(s):  
Robert Baughman ◽  
Jeffrey Kotzin ◽  
Elyse E Lower
Keyword(s):  
Global Assessment ◽  
Well Being ◽  
Patient Global Assessment ◽  
Outcome Instrument ◽  
Time Period ◽  
Significant Difference ◽  
Anti Inflammatory ◽  
A Prospective Study ◽  
The University

Abstract The patient global assessment (PGA) is a reported outcome instrument used to gauge the patient’s well-being. We performed a prospective study of patients seen at the University of Cincinnati Sarcoidosis Clinic. Two groups were studied: those at first visit during the time period (Initial) and those seen at least one more time by the same physician (Follow-up). A total of 1006, including 677 Initial visits, occurred during the six month period. Patients who initiated or increased their anti-inflammatory therapy had a significantly lower mean PGA score (ANOVA P<0.001, p<0.05 for increased versus all others). There was no significant difference in initial PGA score based on race, sex, or age. The change in PGA was significantly lower for those who increased medication (ANOVA P<0.001, increased different from all others, p<0.05). The PGA was significantly lower for patients who increased anti-inflammatory therapy initially or at follow-up, however there was overlap between groups.

Sign in / Sign up

Export Citation Format

Share Document